Helix BioPharma Corp. (HBP) - Cash Flow Conversion Efficiency

Latest as of October 2025: -0.076x

Based on the latest financial reports, Helix BioPharma Corp. (HBP) has a cash flow conversion efficiency ratio of -0.076x as of October 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-1.22 Million ≈ $-883.98K USD) by net assets (CA$16.07 Million ≈ $11.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Helix BioPharma Corp. - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Helix BioPharma Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Helix BioPharma Corp. debt and liabilities for a breakdown of total debt and financial obligations.

Helix BioPharma Corp. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Helix BioPharma Corp. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Biosyent Inc. V:RX	0.069x
Able Global Bhd KLSE:7167	0.080x
Centrica PLC LSE:CNA	0.125x
Cystech Electronics Corp TWO:6651	0.066x
American Outdoor Brands Inc NASDAQ:AOUT	-0.078x
Dardanel Onentas Gida Sanayi AS IS:DARDL	0.287x
Allied Tecnologia S.A SA:ALLD3	1.206x
Faze Three Limited NSE:FAZE3Q	0.025x

Annual Cash Flow Conversion Efficiency for Helix BioPharma Corp. (2007–2025)

The table below shows the annual cash flow conversion efficiency of Helix BioPharma Corp. from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see HBP market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-07-31	CA$15.59 Million ≈ $11.27 Million	CA$-3.83 Million ≈ $-2.77 Million	-0.246x	-100.42%
2024-07-31	CA$-90.00K ≈ $-65.10K	CA$-5.22 Million ≈ $-3.78 Million	57.989x	+785.52%
2023-07-31	CA$-844.00K ≈ $-610.54K	CA$-5.53 Million ≈ $-4.00 Million	6.549x	+132.09%
2022-07-31	CA$319.00K ≈ $230.76K	CA$-6.51 Million ≈ $-4.71 Million	-20.404x	-405.50%
2021-07-31	CA$-1.39 Million ≈ $-1.01 Million	CA$-9.30 Million ≈ $-6.73 Million	6.679x	+283.91%
2020-07-31	CA$2.98 Million ≈ $2.16 Million	CA$-10.83 Million ≈ $-7.83 Million	-3.632x	-315.43%
2019-07-31	CA$-3.28 Million ≈ $-2.37 Million	CA$-5.53 Million ≈ $-4.00 Million	1.686x	-65.79%
2018-07-31	CA$-1.53 Million ≈ $-1.10 Million	CA$-7.52 Million ≈ $-5.44 Million	4.927x	-99.10%
2017-07-31	CA$-17.00K ≈ $-12.30K	CA$-9.29 Million ≈ $-6.72 Million	546.765x	+19640.99%
2016-07-31	CA$3.16 Million ≈ $2.29 Million	CA$-8.85 Million ≈ $-6.40 Million	-2.798x	-125.05%
2015-07-31	CA$6.83 Million ≈ $4.94 Million	CA$-8.49 Million ≈ $-6.14 Million	-1.243x	-10.09%
2014-07-31	CA$6.81 Million ≈ $4.93 Million	CA$-7.69 Million ≈ $-5.56 Million	-1.129x	+28.89%
2013-07-31	CA$4.92 Million ≈ $3.56 Million	CA$-7.81 Million ≈ $-5.65 Million	-1.588x	+29.95%
2012-07-31	CA$6.22 Million ≈ $4.50 Million	CA$-14.11 Million ≈ $-10.21 Million	-2.267x	-384.94%
2011-07-31	CA$22.11 Million ≈ $16.00 Million	CA$-10.34 Million ≈ $-7.48 Million	-0.468x	+39.56%
2010-07-31	CA$15.76 Million ≈ $11.40 Million	CA$-12.19 Million ≈ $-8.82 Million	-0.774x	-0.33%
2009-07-31	CA$17.06 Million ≈ $12.34 Million	CA$-13.16 Million ≈ $-9.52 Million	-0.771x	-126.16%
2008-07-31	CA$20.52 Million ≈ $14.85 Million	CA$-7.00 Million ≈ $-5.06 Million	-0.341x	+28.58%
2007-07-31	CA$12.73 Million ≈ $9.21 Million	CA$-6.08 Million ≈ $-4.40 Million	-0.477x	--

About Helix BioPharma Corp.

TO:HBP Canada Biotechnology

Market Cap

$116.58 Million

CA$161.16 Million CAD

Market Cap Rank

#18609 Global

#616 in Canada

Share Price

CA$2.11

Change (1 day)

+6.57%

52-Week Range

CA$0.90 - CA$5.31

All Time High

CA$11.25